![Pieter van Rompay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pieter van Rompay
Chief Executive Officer at
Labo Phytophar NV
Net worth: 5 M $ as of 31/07/2026
Profile
Pieter van Rompay has worked as a Director at EXO Biologics SA since 2019 and as a Managing Director & Director at Labo Phytophar NV since 2020.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Hyloris Pharmaceuticals SA
 Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs 3.27% | 31/03/2026 | 915,612 ( 3.27% ) | 5 M $ | 31/07/2026 |
Pieter van Rompay active positions
| Companies | Position | Start |
|---|---|---|
EXO Biologics SA
 EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | 29/08/2019 |
Labo Phytophar NV
 Labo Phytophar NV Food: Specialty/CandyConsumer Non-Durables Manufactures medicaments, condiments and seasonings | Chief Executive Officer | 30/10/2019 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
EXO Biologics SA
EXO Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Labo Phytophar NV
Labo Phytophar NV Food: Specialty/CandyConsumer Non-Durables Manufactures medicaments, condiments and seasonings | Consumer Non-Durables |
- Stock Market
- Insiders
- Pieter van Rompay
